Abstract:Colorectal cancer (CRC) represents a significant challenge in oncology, with increasing incidence and mortality rates worldwide, particularly among younger adults. Despite advancements in treatment modalities, the urgent need for more effective therapies persists. Immunotherapy has emerged as a beacon of hope, offering the potential for improved outcomes and quality of life. This review delves into the critical interplay between ferroptosis, an iron-dependent form of regulated cell death, and immunotherapy within the CRC context. Ferroptosis's influence extends beyond tumor cell fate, reshaping the tumor microenvironment (TME) to enhance immunotherapy's efficacy. Investigations into Ferroptosis-related Genes (OFRGs) reveal their pivotal role in modulating immune cell infiltration and TME composition, closely correlating with tumor responsiveness to immunotherapy. The integration of ferroptosis inducers with immunotherapeutic strategies, particularly through novel approaches like ferrotherapy and targeted co-delivery systems, showcases promising avenues for augmenting treatment efficacy. Furthermore, the expression patterns of OFRGs offer novel prognostic tools, potentially guiding personalized and precision therapy in CRC. This review underscores the emerging paradigm of leveraging ferroptosis to bolster immunotherapy's impact, highlighting the need for further research to translate these insights into clinical advancements. Through a deeper understanding of the ferroptosis-immunotherapy nexus, new therapeutic strategies can be developed, promising enhanced efficacy and broader applicability in CRC treatment, ultimately improving patient outcomes and quality of life in the face of this formidable disease.

The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions

Exploring Ferroptosis-Inducing Therapies for Cancer Treatment: Challenges and Opportunities

Ferroptosis in cancer therapy: a novel approach to reversing drug resistance

Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications

Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects

Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy

Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges

Emerging role of tumor microenvironmental nutrients and metabolic molecules in ferroptosis: Mechanisms and clinical implications

Ferroptosis and the tumor microenvironment

The Role of Ferroptosis in Cancer Development and Treatment Response

Emerging roles of ferroptosis in the tumor immune landscape: from danger signals to anti-tumor immunity

Ferroptosis-Mediated Formation of Tumor-Promoting Immune Microenvironment

The Pivotal Role of Ferroptosis in Modulating the Tumor Microenvironment

Ferroptosis, a subtle talk between immune system and cancer cells: To be or not to be?

Ferroptosis in cancer and cancer immunotherapy

Ferroptosis: a double-edged sword mediating immune tolerance of cancer

Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects

Ferroptosis, radiotherapy, and combination therapeutic strategies

Ferroptosis is an effective strategy for cancer therapy

Roles of ferroptosis in urologic malignancies

The role of ferroptosis in prostate cancer: a novel therapeutic strategy